ES8103058A1 - Un procedimiento para la preparacion de un derivado de imi- dazolidindiona - Google Patents

Un procedimiento para la preparacion de un derivado de imi- dazolidindiona

Info

Publication number
ES8103058A1
ES8103058A1 ES489752A ES489752A ES8103058A1 ES 8103058 A1 ES8103058 A1 ES 8103058A1 ES 489752 A ES489752 A ES 489752A ES 489752 A ES489752 A ES 489752A ES 8103058 A1 ES8103058 A1 ES 8103058A1
Authority
ES
Spain
Prior art keywords
phenyl
preparation
pharmaceutical compositions
formulas
positions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES489752A
Other languages
English (en)
Spanish (es)
Other versions
ES489752A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES489752A0 publication Critical patent/ES489752A0/es
Publication of ES8103058A1 publication Critical patent/ES8103058A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES489752A 1979-03-21 1980-03-20 Un procedimiento para la preparacion de un derivado de imi- dazolidindiona Expired ES8103058A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/022,400 US4181729A (en) 1979-03-21 1979-03-21 Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives

Publications (2)

Publication Number Publication Date
ES489752A0 ES489752A0 (es) 1981-02-16
ES8103058A1 true ES8103058A1 (es) 1981-02-16

Family

ID=21809395

Family Applications (1)

Application Number Title Priority Date Filing Date
ES489752A Expired ES8103058A1 (es) 1979-03-21 1980-03-20 Un procedimiento para la preparacion de un derivado de imi- dazolidindiona

Country Status (15)

Country Link
US (1) US4181729A (enExample)
EP (1) EP0017379B1 (enExample)
JP (1) JPS55127376A (enExample)
AR (1) AR222695A1 (enExample)
AT (1) ATE1524T1 (enExample)
AU (1) AU516325B2 (enExample)
DE (1) DE3060818D1 (enExample)
DK (1) DK120780A (enExample)
ES (1) ES8103058A1 (enExample)
FI (1) FI800871A7 (enExample)
GR (1) GR67200B (enExample)
IE (1) IE49563B1 (enExample)
IL (1) IL59615A0 (enExample)
PH (1) PH13951A (enExample)
PT (1) PT70981A (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4283409A (en) * 1979-10-29 1981-08-11 Pfizer Inc. Imidazolone derivatives
US4490381A (en) * 1979-11-13 1984-12-25 Imperial Chemical Industries Plc 1'-Substituted spiro[imidazolidine-4,3'-indoline]2,2',5-triones
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
US4486428A (en) * 1982-03-16 1984-12-04 Pfizer Inc. Bicyclic benzo fused compounds
US4841078A (en) * 1982-03-16 1989-06-20 Pfizer Inc. Benzopyrans
US4870084A (en) * 1982-03-16 1989-09-26 Pfizer Inc. Bicyclic benzo fused pyran compounds used for nausea treatment and prevention
US4863934A (en) * 1982-03-16 1989-09-05 Pfizer Inc. Bicyclic benzo fused pyran compounds used for producing analgesia
US4464385A (en) * 1982-04-15 1984-08-07 Alcon Laboratories, Inc. Treatment of diabetic complications with hydantoins
IL68314A0 (en) * 1982-04-15 1983-07-31 Alcon Lab Inc Method and composition for inhibiting aldose reductase activity and process for preparing spirofluorofluoren and spiro-difluorofluoren compounds
US4438272A (en) 1982-04-15 1984-03-20 Alcon Laboratories, Inc. Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
US4436745A (en) 1982-04-15 1984-03-13 Alcon Laboratories, Inc. Method of inhibiting aldose reductase activity
HU193191B (en) * 1982-12-06 1987-08-28 Pfizer Process for preparing spiro-hetero-azolones
US4556670A (en) * 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications
DE3561198D1 (en) * 1984-03-23 1988-01-28 Pfizer Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications
US5340829A (en) * 1984-11-20 1994-08-23 Washington Research Foundation Immunoregulatory agents
US4966911A (en) * 1984-11-20 1990-10-30 Washington Research Foundation Immunoregulatory agents
EP0536119A4 (en) * 1989-02-10 1993-08-04 Washington Research Foundation Immunoregulatory agents
DK0384416T3 (da) * 1989-02-22 1994-02-28 Sanwa Kagaku Kenkyusho Co Farmaceutisk sammensætning indeholdende hydantoinderivat
DE10210195B4 (de) 2002-03-07 2005-12-15 Schwarz Pharma Ag Verwendung von 1,3-Diazaspiro-[4,5]decan-2,4-dithion zur Behandlung von Schmerz
PT3013796T (pt) * 2013-06-27 2020-03-26 Lg Chemical Ltd Derivados biarílicos como agonistas de gpr120
US11926601B1 (en) 2023-08-29 2024-03-12 King Faisal University 5-spiro 9,10-dihydroanthracene derivative of imidazolidine-2,4-dione as an anticancer agent
WO2026119245A1 (zh) * 2024-12-04 2026-06-11 北京望实智慧科技有限公司 用于降解人原癌基因vav1蛋白(vav1)的化合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2716648A (en) * 1955-08-30 Hydantoin derivatives
US2872454A (en) * 1959-02-03 Spiro-hydantoins from x-chloro-
DE1135915B (de) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
DE2814256A1 (de) * 1977-04-05 1978-10-12 Ciba Geigy Ag Schmieroelzusatzstoffe
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4127665A (en) * 1978-01-18 1978-11-28 Pfizer Inc. Thienohydantoin derivatives

Also Published As

Publication number Publication date
FI800871A7 (fi) 1981-01-01
AR222695A1 (es) 1981-06-15
ATE1524T1 (de) 1982-09-15
EP0017379B1 (en) 1982-09-08
GR67200B (enExample) 1981-06-24
DK120780A (da) 1980-09-22
EP0017379A1 (en) 1980-10-15
DE3060818D1 (en) 1982-10-28
PH13951A (en) 1980-11-06
AU5662480A (en) 1980-09-25
AU516325B2 (en) 1981-05-28
ES489752A0 (es) 1981-02-16
IE49563B1 (en) 1985-10-30
JPS55127376A (en) 1980-10-02
US4181729A (en) 1980-01-01
IE800571L (en) 1980-09-21
PT70981A (en) 1980-04-01
JPH0141629B2 (enExample) 1989-09-06
IL59615A0 (en) 1980-06-30

Similar Documents

Publication Publication Date Title
IL51297A (en) Proline derivatives and related compounds pharmaceutical compositions containing the same and process for the preparation thereof
ES8302025A1 (es) Procedimiento para la preparacion de 10-alquinil esteroides
ES480951A1 (es) Un procedimiento para la preparacion de un agente tixotropi-co.
IT1209124B (it) Derivati dell'acido arilsolfinico di composti alifatici, aromatici o eterociclici.
BG31467A3 (bg) Хербицидно средство и метод за борба с нежелана растителност
ES8601932A1 (es) Un procedimiento para la preparacion de derivados de 1,2,4- triazol que contienen fluor
SE7811753L (sv) Nya oximderivat av3-substituerad 7-amino-tiazolyl-acetamido-cafalosporansyra, sett for framstellning derav och farmaceutiska kompositioner innehallande dessa derivat
AR220094A1 (es) Derivados de 3-alquil(c3-c6)o 3-cicloalquil c3-c6)-5-aminoisoxasol,composiciones herbicidas que los contienen y procedimiento para prepararlos
AR218889A1 (es) Nuevos derivados del nitrilo del acido 3-hidroxi-2-(4-fenil-2-tiazolil)-cinamico,composiciones plaguicidas que los contienen y procedimiento para prepararlos
JPS56103168A (en) Thiazole derivative, its preparation, and antihistaminic agent containing the same
SE7707689L (sv) 2-brom-6-fluor-n-2-imidazolidinylidenbensamin dess syraadditionssalter, lekemedel innehallande dessa och forfarande for framstellning derav
SE7702668L (sv) Nya stilbenforeningar och forfarande for deras framstellning
ES8205750A1 (es) Un procedimiento para la preparacion de nuevos derivados de fenetilamina.
ES8504759A1 (es) Un procedimiento para la preparacion de nuevos derivados de 5-hidroxi-3,4-dihidro-2h-benzopirano
ES8609302A1 (es) Un procedimiento para la preparacion de 4-amino-2-fenilqui- nolinas
FI812470L (fi) 7-beta-/alfa-syn-metoxi-imino-alfa-(2-aminotiatsol-4-yl)acetamido)-3-((1,2,3-tiadiatsol-5-yltio)metyl)-3-cefem-4-karboxylsyra och dess c1-6-alkylderivat
DE3172383D1 (en) Preparation of thiazolidine derivatives
PT85100A (pt) Processo para a preparacao de novos tetra-hidro-benzotiazois e de composicoes farmaceuticas que os contem
IT7826317A0 (it) Composizioni oftalmiche contenenti derivati di acido isochinoin-acetico.
ES8103090A1 (es) Un procedimiento para la preparacion de espiro-quinolilludantoinas, utiles como inhibidores de la aldosa-reductasa para el tratamiento de las complicaciones cronicas de la diabetes
ES457197A1 (es) Procedimiento para preparar carbamatos de oxima.
JPS5740496A (en) Low toxic derivative of istamycin antibiotic
IT1164969B (it) Derivati della fenilurea, procedimento per la preparazione di questi composti e mezzi erbicidi che li contengono
AR222510A1 (es) Nuevos derivados de acido 1,3,4-tiadizol-2-carboxilicos,procedimientos para producirlos y composiciones fungicidas y nematodicidas que los contienen
SE8001235L (sv) 2,2-dimetyl-1,2-dihydrokinolinderivat anvendbara som antioxidanter, jemte sett for deras framstellning och blandningar innehallande dem